Coty (COTY)
(Real Time Quote from BATS)
$9.24 USD
+0.05 (0.54%)
Updated Sep 23, 2024 11:53 AM ET
3-Hold of 5 3
B Value C Growth F Momentum C VGM
Price, Consensus and EPS Surprise
COTY 9.24 +0.05(0.54%)
Will COTY be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for COTY based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for COTY
Why Is Coty (COTY) Down 8.6% Since Last Earnings Report?
Is e.l.f. Beauty Stock a Buy, Sell or Hold at a P/E Multiple of 28.8X?
COTY: What are Zacks experts saying now?
Zacks Private Portfolio Services
EL Trading Near 52-Week Low: How Should Investors Approach the Stock?
Coty Thrives in the Growing Beauty Space Despite Cost Challenges
Coty (COTY) Reliance on International Sales: What Investors Need to Know
Other News for COTY
Interesting COTY Call Options For May 2025
Orveda, the French multi-award-winning biotech skincare brand, unveils LA MAISON ORVEDA NEW YORK CITY, a wellness sanctuary dedicated to glow and skin longevity, located in the heart of the Upper East Side.
Repairing Olaplex: 3 Catalysts That Evidence A Turnaround
e.l.f. Beauty sales growth starts to fade
Columbia Contrarian Core Fund Q2 2024 Investment Commentary